2-hydroxy-1-nitro-3,4,5-trimethoxybenzene | 142004-00-0

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: 2-hydroxy-1-nitro-3,4,5-trimethoxybenzene
• 英文别名: 5-Nitro-4-hydroxy-1,2,3-trimethoxy-benzol；6-Nitro-2,3,4-trimethoxyphenol；2,3,4-trimethoxy-6-nitrophenol
• CAS: 142004-00-0
• 化学式: C₉H₁₁NO₆
• 分子量: 229.189
• InChiKey: LPINJRDUKQKHKZ-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.9
• 重原子数：
  16
• 可旋转键数：
  3
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.33
• 拓扑面积：
  93.7
• 氢给体数：
  1
• 氢受体数：
  6

反应信息

• 作为反应物：
  描述：

  2-hydroxy-1-nitro-3,4,5-trimethoxybenzene 在 tin(II) chloride dihdyrate 、 potassium carbonate 、 三乙胺 作用下， 以 二氯甲烷 、 乙酸乙酯 、 N,N-二甲基甲酰胺 为溶剂， 反应 32.0h， 生成 2-(benzyloxy)-N-(2-(benzyloxy)-3,4,5-trimethoxyphenyl)-4-methoxybenzamide
  参考文献：
  名称：

  四唑系考布他汀类似物的氢键倾向与抗癌特性的相关性

  摘要：

  一系列 1,5-二取代四唑束缚的考布他汀类似物在邻位具有扩展的氢键供体开发了芳基 A 和 B 环的 - 位并评估了它们的抗微管蛋白和抗增殖活性。我们想测试在这些类似物中用作构象锁定元件的分子内氢键是否会提高它们的活性。晶体结构与修饰类似物的抗微管蛋白和抗增殖谱的相关性表明，氢键介导的 A 环构象控制对生物活性有害。相比之下，虽然没有明确的证据表明 B 环上的分子内氢键增强了活性，但我们发现 B 环上的取代增加对抗微管蛋白和抗增殖活性有积极影响。在合成的各种类似物中，化合物5d和5e在 4-甲氧基苯基 B 环的邻位和间位具有氢键供体基团，是微管蛋白聚合的强抑制剂和具有微摩尔浓度IC 50值的抗增殖剂。

  DOI：

  10.1016/j.bmcl.2013.06.004
• 作为产物：
  描述：

  3,4,5-trimethoxysalicylic acid 在 硝酸 作用下， 以 溶剂黄146 为溶剂， 生成 2-hydroxy-1-nitro-3,4,5-trimethoxybenzene
  参考文献：
  名称：

  Graesslin,D. et al., Chemische Berichte, 1967, vol. 100, p. 3077 - 3083

  摘要：

  DOI：

文献信息

• Cyclic diamine compound with condensed-ring groups
  申请人：Kowa Co., Ltd.

  公开号：US20030060461A1

  公开（公告）日：2003-03-27

  A cyclic diamine compound of formula (1): 1 wherein R 1 and R 2 are individually a hydrogen atom or a methoxy group, provided R 1 is a methoxy group when R 2 is a hydrogen atom, or a hydrogen atom when R 2 is a methoxy group; A is an oxygen atom, a sulfur atom, CH═CH, CH═N or NR 3 , in which R 3 is a hydrogen atom, or a lower alkyl, hydroxy lower alkyl, lower alkoxy lower alkyl, aryl or aryl lower alkyl group; B is a nitrogen atom, CH or CR 4 , in which R 4 is a hydrogen atom, or a lower alkyl, hydroxy lower alkyl, lower alkoxy lower alkyl, aryl or aryl lower alkyl group; m is 1 or 2; and n is a number of 1 to 5, an acid-addition salt thereof, or a hydrate thereof. The compound has inhibitory effects on cell adhesion and is useful for treatment of allergy, asthma, rheumatism, arteriosclerosis, and inflammation.

  公式（1）所示的环状二胺化合物：1 其中R1和R2分别是个别氢原子或甲氧基，条件是当R2是氢原子时R1是甲氧基，或者当R2是甲氧基时R1是氢原子；A是氧原子、硫原子、CH═CH、CH═N或NR3，其中R3是氢原子，或者是低级烷基、羟基低级烷基、低级烷氧基低级烷基、芳基或芳基低级烷基团；B是氮原子、CH或CR4，其中R4是氢原子，或者是低级烷基、羟基低级烷基、低级烷氧基低级烷基、芳基或芳基低级烷基团；m是1或2；n是1到5的数字，其酸加成盐，或其水合物。该化合物具有抑制细胞粘附的作用，并且对于治疗过敏、哮喘、风湿病、动脉硬化以及炎症是有用的。
• Multisubstituted 1-hydroxy-9-acridones with anticancer activity
  申请人：Sloan-Kettering Institute for Cancer Research

  公开号：US05296602A1

  公开（公告）日：1994-03-22

  The present invention provides a compound having the structure: ##STR1## The present invention also provides a method for synthesizing a compound having the above-identified structure as well as the intermediate compounds produced according to that method. The present invention further provides a pharmaceutical composition comprising the above compounds. Lastly, the present invention provides a method of inhibiting growth of tumor cells.

  本发明提供了一种具有以下结构的化合物：##STR1## 本发明还提供了一种合成具有上述结构的化合物的方法，以及根据该方法产生的中间化合物。本发明还提供了包括上述化合物的药物组合物。最后，本发明提供了一种抑制肿瘤细胞生长的方法。
• CYCLIC DIAMINE COMPOUNDS HAVING FUSED-RING GROUPS
  申请人：Kowa Co., Ltd.

  公开号：EP1400510A1

  公开（公告）日：2004-03-24

  A cyclic diamine compound of formula (1): wherein R1 and R2 are individually a hydrogen atom or a methoxy group, provided R1 is a methoxy group when R2 is a hydrogen atom, or a hydrogen atom when R2 is a methoxy group; A is an oxygen atom, a sulfur atom, CH=CH, CH=N or NR3, in which R3 is a hydrogen atom, or a lower alkyl, hydroxy lower alkyl, lower alkoxy lower alkyl, aryl or aryl lower alkyl group; B is a nitrogen atom, CH or CR4, in which R4 is a hydrogen atom, or a lower alkyl, hydroxy lower alkyl, lower alkoxy lower alkyl, aryl or aryl lower alkyl group; m is 1 or 2; and n is a number of 1 to 5, an acid-addition salt thereof, or a hydrate thereof. The compound has inhibitory effects on cell adhesion and is useful for treatment of allergy, asthma, rheumatism, arteriosclerosis, and inflammation.

  一种式(1)的环状二胺化合物： 其中 R1 和 R2 分别为氢原子或甲氧基，条件是当 R2 为氢原子时 R1 为甲氧基，或当 R2 为甲氧基时为氢原子；A 为氧原子、硫原子、CH=CH、CH=N 或 NR3，其中 R3 为氢原子，或低级烷基、羟基低级烷基、低级烷氧基低级烷基、芳基或芳基低级烷基；B是氮原子、CH或CR4，其中R4是氢原子、或低级烷基、羟基低级烷基、低级烷氧基低级烷基、芳基或芳基低级烷基；m是1或2；n是1至5的数字、其酸加成盐或其水合物。该化合物对细胞粘附有抑制作用，可用于治疗过敏、哮喘、风湿病、动脉硬化和炎症。
• Synthesis of the acridone alkaloids, glyfoline and congeners. Structure-activity relationship studies of cytotoxic acridones
  作者：Tsann Long Su、Bernd Kohler、Ting Chao Chou、Moon Woo Chun、Kyoichi A. Watanabe

  DOI：10.1021/jm00092a022

  日期：1992.7

  Glyfoline (4, 1,6-dihydroxY-10-methyl-2,3,4,5-tetramethoxyacridin-9-one) and its congeners were synthesized for evaluation of their cytotoxicity. A detailed structure-activity relationships (SAR) of these acridone derivatives were also studied. To study the SAR of glyfoline analogues, substituent(s) at C-1 and C-6 and at the heterocyclic nitrogen of glyfoline nucleus were modified. Nitro- and amino-substituted glyfoline analogues were also synthesized to study the effects of substituent(s) (electron-withdrawing vs electron-donating) on their cytotoxicity. These compounds were synthesized via the Ullmann condensation of anthranilic acids with iodobenzenes or 2-chlorobenzoic acids with aniline-derivatives. The SAR studies showed that 1-hydroxy 9-acridones were more active than their 1-OMe derivatives against cell growth of human leukemic HL-60 cells in culture. Replacement of NMe of glyfoline with NH or N(CH2)2NEt2 resulted in either total loss or dramatic reduction of cytotoxity. Glyfoline congeners with nitro function at the A-ring were inactive, while compounds with amino substituent were shown to be cytotoxic in vitro.
• US5296602A
  申请人：——

  公开号：US5296602A

  公开（公告）日：1994-03-22